Abstract
THIS ARTICLE HAS BEEN RETRACTED.
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Title:Retraction Notice: Participation of Maternal and Fetal CRH in Early Phases of Human Implantation: The Role of Antalarmin
Volume: 4 Issue: 1
Author(s): A. Makrigiannakis*, E. Zoumakis, S. Kalantaridou, G. Chrousos and A. Gravanis
Affiliation:
- Dept of Ob/Gyn Medical School, University of Crete, Heraklion 71110,Greece
Abstract: THIS ARTICLE HAS BEEN RETRACTED.
Export Options
About this article
Cite this article as:
Makrigiannakis A.*, Zoumakis E., Kalantaridou S., Chrousos G. and Gravanis A., Retraction Notice: Participation of Maternal and Fetal CRH in Early Phases of Human Implantation: The Role of Antalarmin, Current Drug Targets - Immune, Endocrine & Metabolic Disorders 2004; 4 (1) . https://dx.doi.org/10.2174/1568005310404010075
DOI https://dx.doi.org/10.2174/1568005310404010075 |
Print ISSN 1568-0088 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5917 |